Medicare Coverage For New FDA-Approved Alzheimer’s Treatment, Leqembi: Groundbreaking Progress In Healthcare!
Introduction On Thursday, the U.S. Food and Drug Administration (FDA) achieved a significant milestone in Alzheimer’s treatment. It granted full approval to the Alzheimer’s treatment drug Leqembi, a collaborative product of Biogen BIIB and Eisai Co. Ltd. ESALF. This groundbreaking move provides assurance for Medicare reimbursement for the first-ever drug confirmed to slow down the […]
“FDA Committee Greenlights Over-The-Counter Birth Control Pills: Empowering Women’s Health Choices!”
US Food and Drug Administration (FDA) advisory committees voted unanimously that the advantages of making Opill, a birth control pill, accessible for use without a prescription, would exceed the risks. Perrigo Co. announced the decision in a recent press release. The joint committee’s vote is non-binding; nevertheless, the FDA frequently follows advisory committee recommendations. Perrigo’s […]
“FDA Greenlights Pfizer-BioNTech Boosters: Young Kids with Weakened Immunity Get Added Protection”
The US Food and Drug Administration (FDA) has granted emergency use authorization for Pfizer Inc. and BioNTech SE’s COVID-19 bivalent vaccine for immunocompromised children aged six months through four years. This marks the first time a fourth dose of a COVID-19 vaccine has been authorized for young children in this age group. The additional shot […]
FDA Fast-Tracks Biogen’s Breakthrough Cure for Exceedingly Rare ALS Variant
The US Food and Drug Administration (FDA) has granted accelerated approval to Biogen’s new treatment for a rare form of amyotrophic lateral sclerosis (ALS), allowing patients to access the therapy more quickly. The approval was given to Biogen’s drug Torferson for use in those suffering from the neuromuscular disorder, which is also known as Lou Gehrig’s disease […]
FDA Yanks Makena & Generics off Shelves: Preterm-Birth Drug Deemed Ineffective after 12-Year Reign
The US Food and Drug Administration (FDA) has announced that it has reached a final decision to withdraw approval for Makena, a drug used to prevent preterm birth, and its generic counterparts. The decision comes 12 years after the drug was first approved and made available on the market. Makena was approved in 2011 using […]